Atlas FDA

VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD (ESBL)

FDA premarket approval N50510/S081 · decided 1998-08-14

Approval details

PMA number
N50510
Supplement
S081
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD (ESBL)
Generic name
Susceptibility test cards, antimicrobial
Applicant
Biomerieux Vitek, Inc.
Date received
1998-04-22
Decision date
1998-08-14
Days to decision
114 days
Decision code
APPR
Product code
LTW
Advisory committee
Microbiology
Expedited review
No
Location
Hazelwood, MO
Statement
Approval for the testing of Escherichia coli, Klebsiella pneumoniae, and K. oxytoca for the presence of extended-spectrum beta lactamases (ESBL).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VIDAS D-DIMER (DD) ASSAY (K973819)Biomerieux Vitek, Inc.1998-03-10
VIDAS ROTAVIRUS (RTV) ASSAY (K972895)Biomerieux Vitek, Inc.1997-10-03
VIDAS ROTAVIRUS ASSAY (K965092)Biomerieux Vitek, Inc.1997-05-05
VIDAS C. DIFFICILE TOXIN A II ASSAY (K964887)Biomerieux Vitek, Inc.1997-04-08
VIDAS CHLAMYDIA BLOCKING ASSAY (K955627)Biomerieux Vitek, Inc.1996-10-07
VIDAS CREATINE KINASE MB ASSAY 30-421 (K962549)Biomerieux Vitek, Inc.1996-08-30
GRAM NEGATIVE IDENTIFICATION PLUS CARD (K962609)Biomerieux Vitek, Inc.1996-08-30
VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI) (K952095)Biomerieux Vitek, Inc.1996-03-12